Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:UROV

Urovant Sciences (UROV) Stock Price, News & Analysis

Urovant Sciences logo

About Urovant Sciences Stock (NASDAQ:UROV)

Advanced Chart

Key Stats

Today's Range
$16.24
$16.24
50-Day Range
$16.19
$16.24
52-Week Range
$7.15
$16.26
Volume
N/A
Average Volume
114,469 shs
Market Capitalization
$531.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive UROV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Urovant Sciences and its competitors with MarketBeat's FREE daily newsletter.

UROV Stock News Headlines

Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
See More Headlines

UROV Stock Analysis - Frequently Asked Questions

Urovant Sciences Ltd. (NASDAQ:UROV) posted its quarterly earnings data on Thursday, February, 11th. The company reported ($1.46) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.59) by $0.13.

Urovant Sciences (UROV) raised $150 million in an initial public offering (IPO) on Thursday, September 27th 2018. The company issued 10,000,000 shares at $14.00-$16.00 per share. J.P. Morgan, Jefferies and Cowen served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Urovant Sciences investors own include Fulcrum Therapeutics (FULC), Sorrento Therapeutics (SRNE), Xeris Biopharma (XERS), Akero Therapeutics (AKRO), Aldeyra Therapeutics (ALDX), Idera Pharmaceuticals (IDRA) and Kaleido Biosciences (KLDO).

Company Calendar

Last Earnings
2/11/2021
Today
7/11/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:UROV
CIK
1740547
Fax
N/A
Employees
70
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($4.71)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$146.74 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-162.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.91
Quick Ratio
2.91

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.90) per share
Price / Book
-8.55

Miscellaneous

Outstanding Shares
32,743,000
Free Float
N/A
Market Cap
$531.75 million
Optionable
Not Optionable
Beta
2.36
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:UROV) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners